Impact on funding rounds
How R&D enquiries can affect a business during a funding round and introduce an issue that investors may need to understand and assess.
This downloadable report examines an often overlooked downside of R&D tax credits for venture capital firms. While credits are frequently viewed as non-dilutive funding, poorly prepared claims can create wider disruption when they come under HMRC scrutiny.
Receive your copyThe report looks beyond the immediate value of an R&D tax credit and considers what can happen when a claim within an investment portfolio comes under scrutiny.
How R&D enquiries can affect a business during a funding round and introduce an issue that investors may need to understand and assess.
Why the potential exposure should not always be considered at individual company level, particularly where several portfolio businesses make R&D claims.
The areas that can leave an R&D tax claim more difficult to support when HMRC examines the underlying basis for it.
What businesses and investors should expect from a robust claim that can be supported when it comes under scrutiny.
Complete the form to receive our report on R&D tax credits and the potential risks for venture capital portfolios.
We will send the report directly to the email address provided.